Status:
COMPLETED
Failure Factors of ERCP After Gastrointestinal Reconstruction and Effectiveness Analysis of Remedial Measures
Lead Sponsor:
Beijing Friendship Hospital
Conditions:
Endoscopic Retrograde Cholangiopancreatography
Eligibility:
All Genders
18+ years
Brief Summary
This is a retrospective study, including 195 patients with gastrointestinal reconstruction, who treated with Endoscopic Retrograde Cholangiopancreatography (ERCP) at Beijing friendship hospital. The i...
Detailed Description
Endoscopic retrograde cholangiopancreatography (ERCP) is an invasive procedure in which an endoscope is inserted into the descending part of the duodenum through the duodenal papilla, and special inst...
Eligibility Criteria
Inclusion
- Age ≥18 years old.
- After gastrointestinal reconstruction (Billroth Ⅱ Anastomosis, Roux-en-Y Anastomosis).
- Endoscopic retrograde cholangiopancreatography (ERCP) was performed for common bile duct stone with choledocholithiasis, pancreatic duct stenosis, or obstructive jaundice with endoscopic indication.
Exclusion
- After Billroth I Anastomosis.
- Accompanied by serious cardiopulmonary disease or coagulation dysfunction.
Key Trial Info
Start Date :
April 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT06512246
Start Date
April 1 2024
End Date
July 1 2024
Last Update
July 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Friendship Hospital
Beijing, Beijing Municipality, China, 100050